Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Hepatitis C

Free Subscription Articles published in Proc Natl Acad Sci U S A Retrieve available abstracts of 22 articles: HTML format Text format

Single Articles

December 2017
1. MANKOWSKI MC, Kinchen VJ, Wasilewski LN, Flyak AI, et al
   Synergistic anti-HCV broadly neutralizing human monoclonal antibodies with independent mechanisms.
   Proc Natl Acad Sci U S A. 2017 Dec 18. pii: 1718441115.
   PubMed     Text format     Abstract available
   
   
   
2. 
   Correction for Giang et al., Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus.
   Proc Natl Acad Sci U S A. 2017 Dec 11. pii: 1720228115.
   PubMed     Text format    
   
   
   November 2017
3. HIRANO J, Okamoto T, Sugiyama Y, Suzuki T, et al
   Characterization of SPP inhibitors suppressing propagation of HCV and protozoa.
   Proc Natl Acad Sci U S A. 2017 Nov 29. pii: 1712484114.
   PubMed     Text format     Abstract available
   
   
   May 2017
4. PADMANABHAN P, Dixit NM
   Inhibitors of hepatitis C virus entry may be potent ingredients of optimal drug combinations.
   Proc Natl Acad Sci U S A. 2017 May 16. pii: 201704531.
   PubMed     Text format    
   
   
   
5. OHASHI H, Koizumi Y, Fukano K, Wakita T, et al
   Reply to Padmanabhan and Dixit: Hepatitis C virus entry inhibitors for optimally boosting direct-acting antiviral-based treatments.
   Proc Natl Acad Sci U S A. 2017 May 16. pii: 201705234.
   PubMed     Text format    
   
   
   April 2017
6. HANSEN MD, Johnsen IB, Stiberg KA, Sherstova T, et al
   Hepatitis C virus triggers Golgi fragmentation and autophagy through the immunity-related GTPase M.
   Proc Natl Acad Sci U S A. 2017 Apr 7. pii: 201616683.
   PubMed     Text format     Abstract available
   
   
   March 2017
7. 
   Correction for Koizumi et al., Quantifying antiviral activity optimizes drug combinations against hepatitis C virus infection.
   Proc Natl Acad Sci U S A. 2017 Mar 6. pii: 201702625.
   PubMed     Text format    
   
   
   February 2017
8. KOIZUMI Y, Ohashi H, Nakajima S, Tanaka Y, et al
   Quantifying antiviral activity optimizes drug combinations against hepatitis C virus infection.
   Proc Natl Acad Sci U S A. 2017 Feb 7. pii: 201610197.
   PubMed     Text format     Abstract available
   
   
   
9. QI H, Chu V, Wu NC, Chen Z, et al
   Systematic identification of anti-interferon function on hepatitis C virus genome reveals p7 as an immune evasion protein.
   Proc Natl Acad Sci U S A. 2017 Feb 3. pii: 201614623.
   PubMed     Text format     Abstract available
   
   
   December 2016
10. LIU WL, Yang HC, Hsu CS, Wang CC, et al
    Pegylated IFN-alpha suppresses hepatitis C virus by promoting the DAPK-mTOR pathway.
    Proc Natl Acad Sci U S A. 2016 Dec 6. pii: 201618517.
    PubMed     Text format     Abstract available
    
    
    October 2016
11. PIERCE BG, Keck ZY, Lau P, Fauvelle C, et al
    Global mapping of antibody recognition of the hepatitis C virus E2 glycoprotein: Implications for vaccine design.
    Proc Natl Acad Sci U S A. 2016 Oct 26. pii: 201614942.
    PubMed     Text format     Abstract available
    
    
    
12. KONG L, Lee DE, Kadam RU, Liu T, et al
    Structural flexibility at a major conserved antibody target on hepatitis C virus E2 antigen.
    Proc Natl Acad Sci U S A. 2016 Oct 24. pii: 201609780.
    PubMed     Text format     Abstract available
    
    
    
13. WOZNIAK AL, Long A, Jones-Jamtgaard KN, Weinman SA, et al
    Hepatitis C virus promotes virion secretion through cleavage of the Rab7 adaptor protein RILP.
    Proc Natl Acad Sci U S A. 2016 Oct 17. pii: 201607277.
    PubMed     Text format     Abstract available
    
    
    September 2016
14. HONEGGER JR, Tedesco D, Kohout JA, Prasad MR, et al
    Influence of IFNL3 and HLA-DPB1 genotype on postpartum control of hepatitis C virus replication and T-cell recovery.
    Proc Natl Acad Sci U S A. 2016 Sep 6. pii: 201602337.
    PubMed     Text format     Abstract available
    
    
    June 2016
15. COLPITTS CC, Lupberger J, Baumert TF
    Multifaceted role of E-cadherin in hepatitis C virus infection and pathogenesis.
    Proc Natl Acad Sci U S A. 2016 Jun 24. pii: 201607732.
    PubMed     Text format    
    
    
    
16. LI Q, Sodroski C, Lowey B, Schweitzer CJ, et al
    Hepatitis C virus depends on E-cadherin as an entry factor and regulates its expression in epithelial-to-mesenchymal transition.
    Proc Natl Acad Sci U S A. 2016 Jun 13. pii: 201602701.
    PubMed     Text format     Abstract available
    
    
    February 2016
17. LUSSIGNOL M, Kopp M, Molloy K, Vizcay-Barrena G, et al
    Proteomics of HCV virions reveals an essential role for the nucleoporin Nup98 in virus morphogenesis.
    Proc Natl Acad Sci U S A. 2016 Feb 16. pii: 201518934.
    PubMed     Text format     Abstract available
    
    
    January 2016
18. HAROUAKA D, Engle RE, Wollenberg K, Diaz G, et al
    Diminished viral replication and compartmentalization of hepatitis C virus in hepatocellular carcinoma tissue.
    Proc Natl Acad Sci U S A. 2016 Jan 19. pii: 201516879.
    PubMed     Text format     Abstract available
    
    
    December 2015
19. UJINO S, Nishitsuji H, Hishiki T, Sugiyama K, et al
    Hepatitis C virus utilizes VLDLR as a novel entry pathway.
    Proc Natl Acad Sci U S A. 2015 Dec 23. pii: 201506524.
    PubMed     Text format     Abstract available
    
    
    July 2015
20. MOCKENHAUPT S, Grosse S, Rupp D, Bartenschlager R, et al
    Alleviation of off-target effects from vector-encoded shRNAs via codelivered RNA decoys.
    Proc Natl Acad Sci U S A. 2015;112:E4007-16.
    PubMed     Text format     Abstract available
    
    
    
21. SUNG PS, Cheon H, Cho CH, Hong SH, et al
    Roles of unphosphorylated ISGF3 in HCV infection and interferon responsiveness.
    Proc Natl Acad Sci U S A. 2015 Jul 27. pii: 201513341.
    PubMed     Text format     Abstract available
    
    
    May 2015
22. PRICE AA, Sampson TR, Ratner HK, Grakoui A, et al
    Cas9-mediated targeting of viral RNA in eukaryotic cells.
    Proc Natl Acad Sci U S A. 2015;112:6164-9.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis C is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: